Cargando…

Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]

Detalles Bibliográficos
Autores principales: Andreassen, Bettina K, Hektoen, Helga H, Axcrona, Karol, Langseth, Hilde, Stenehjem, Jo S, Robsahm, Trude E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599866/
https://www.ncbi.nlm.nih.gov/pubmed/34803404
http://dx.doi.org/10.2147/CLEP.S345565
_version_ 1784601034939695104
author Andreassen, Bettina K
Hektoen, Helga H
Axcrona, Karol
Langseth, Hilde
Stenehjem, Jo S
Robsahm, Trude E
author_facet Andreassen, Bettina K
Hektoen, Helga H
Axcrona, Karol
Langseth, Hilde
Stenehjem, Jo S
Robsahm, Trude E
author_sort Andreassen, Bettina K
collection PubMed
description
format Online
Article
Text
id pubmed-8599866
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85998662021-11-19 Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter] Andreassen, Bettina K Hektoen, Helga H Axcrona, Karol Langseth, Hilde Stenehjem, Jo S Robsahm, Trude E Clin Epidemiol Response to Letter Dove 2021-11-08 /pmc/articles/PMC8599866/ /pubmed/34803404 http://dx.doi.org/10.2147/CLEP.S345565 Text en © 2021 Andreassen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Response to Letter
Andreassen, Bettina K
Hektoen, Helga H
Axcrona, Karol
Langseth, Hilde
Stenehjem, Jo S
Robsahm, Trude E
Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title_full Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title_fullStr Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title_full_unstemmed Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title_short Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title_sort prediagnostic serum-25 hydroxyvitamin d and mortality among bladder cancer patients in the janus serum bank cohort: answer to a short comment [response to letter]
topic Response to Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599866/
https://www.ncbi.nlm.nih.gov/pubmed/34803404
http://dx.doi.org/10.2147/CLEP.S345565
work_keys_str_mv AT andreassenbettinak prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter
AT hektoenhelgah prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter
AT axcronakarol prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter
AT langsethhilde prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter
AT stenehjemjos prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter
AT robsahmtrudee prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter